Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Improved glucose stability Because GLP-1 medications were originally developed for type 2 diabetes, there is evidence from clinical trials to indicate their positive effect on glucose stability, at even lower doses than those needed for maximal weight loss
In fact, among over 14,500 participants across multiple studies assessing the risk of thyroid cancer incidence and the use of semaglutide (the active ingredient in GLP-1 agonists), the risk of thyroid cancer was less than 1%
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone
Toms-Barbern et al., 2016
Ask your healthcare provider about medication No weight loss medications are specifically approved by the US Food and Drug Administration (FDA) for postpartum use
Mounjaro and Zepbound contain the same active drug, tirzepatide, in the same titration ladder
US$ 29.69
US$ 20.62
US$ 20.33
US$ 26.15
US$ 21.20
US$ 20.37
